Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Ureidosuccinic acid is an intermediate in the de novo pyrimidine nucleotide biosynthesis pathway.1,2 It is formed from aspartate and carbamoyl phosphate via aspartate carbamoyltransferase.1 Ureidosuccinic acid (350 mg/kg) inhibits antitumor activity and toxicity induced by the aspartate carbamoyltransferase inhibitor N-phosphonacetyl-L-aspartate (PALA) in a murine Lewis lung carcinoma model.3
WARNING This product is not for human or veterinary use.
1. Studies on the biosynthesis of carbamylaspartic acid. The Journal of Biological Chemisty 220(1), 57-70 (1956).
2. Ureidosuccinic acid as a precursor of nucleic acid pyrimidines in normal and tumor-
3. Reversal of toxicity and antitumor activity of N-